Summary
-
1.
The positive inotropic effects of noradrenaline and of dihydro-ouabain on guinea-pig papillary muscles were compared by analyzing the isometric contraction curves in regard to height (F C ), time to peak force (t 1), relaxation time (t 2), and mean velocities of force development (S 1) and relaxation (S 2).
-
2.
The maximum inotropic effect (Δ F C ) obtained with dihydro-ouabain is 20% greater than that of noradrenaline (p<0.02). The difference is even greater between the maximal klinotropic effects (Δ S 1): i.e., the mean velocity of S 1 reaches a maximum with dihydro-ouabain which lies 50% above that obtained with noradrenaline.
-
3.
Time to peak force (t 1) is shortened by dihydro-ouabain (−25%) more than by noradrenaline (−7%). Relaxation time (t 2) at the end of the concentration-effect curve is reduced 30% by noradrenaline whereas dihydro-ouabain prolongs t 2 by 12%.
-
4.
The opposite effects of dihydro-ouabain and noradrenaline on t 2 reflect their differring influences upon relaxation velocity. The increase in S 2 by the maximally effective concentration of noradrenaline surpasses by about 50% the maximal increase obtained with dihydro-ouabain.
-
5.
The increase in relaxation velocity (Δ S 2) by noradrenaline in a maximally effective concentration exceeds its klinotropic effect (Δ S 1) by about 60%. The effect of noradrenaline on ventricular muscle, therefore, predominantly enhances relaxation, as at β-adrenoceptors of smooth muscle. The enhancement of the relaxation by noradrenaline probably limits the positive inotropic effect of this drug and leads to the flatness of the concentration-effect curves in regard to Δ F C and Δ S 1, and to a characteristic bending in the slope of the isometric contraction curve.
-
6.
Dihydro-ouabain causes a relative retardation in relaxation velocity: the increase in S 2 by maximally effective concentrations in 34% less than its positive klinotropic effect. This suggest an interference with the relaxation process by high concentrations of the glycoside which thus might contribute to its positive inotropic effect.
Similar content being viewed by others
References
Brady, A. J.: The development of tension in cardiac muscle. In: Pharmacology of cardiac function, pp. 15–23. O. Krayer, ed. Oxford: Pergamon-Press 1964.
Brandt, W., Reiter, M., Seibel, K.: A postsynaptic effect of tyramine in ventricular muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 273, 283–293 (1972a).
Brandt, W., Reiter, M., Seibel, K.: “Supramaximal”. Enhancement of the inotropic effect of noradrenaline by tyramine. Naunyn-Schmiedeberg's Arch. Pharmacol. 273, 294–306 (1972b).
Engstfeld, G., Antoni, H., Fleckenstein, A.: Die Restitution der Erregungsfortleitung und Kontraktionskraft des K+-gelähmten Frosch- und Säugetiermyokards durch Adrenalin. Pflügers Arch. ges. Physiol. 273, 145–163 (1961).
Koch-Weser, J., Berlin, C. M., Jr., Blinks, J. R.: Effects of acetylstrophanthidin, levarterenol and carbachol on the interval-strength relationship of heart muscle. In: Pharmacology of cardiac function, pp. 63–72. O. Krayer, ed. Oxford: Pergamon-Press 1964.
Krop, St.: The influence of “heart stimulants” on the contraction of isolated mammalian cardiac muscle. J. Pharmacol. exp. Ther. 82, 48–62 (1944).
Reiter, M.: Der Einfluß der Natriumionen auf die Beziehung zwischen Frequenz und Kraft der Kontraktion des isolierten Meerschweinchenmyokards. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 254, 261–286 (1966).
Reiter, M.: Die Wertbestimmung inotrop wirkender Arzneimittel am isolierten Papillarmuskel. Arzneimittel-Forsch. (Drug Res.) 17, 1249–1253 (1967).
Reiter, M.: Drugs and heart muscle. Ann. Rev. Pharmacol. 12, 111–124 (1972a).
Reiter, M.: Different mechanical responses of ventricular muscle under the action of glycosides and catecholamines. Proc. Fifth Internat. Congr. on Pharmacol. San Francisco 1972 (b), p. 191
Reiter, M., Schöber, H. G.: Die positiv inotrope Adrenalinwirkung auf den Meerschweinchen-Papillarmuskel bei Variation der äußeren Calcium- und Natriumkonzentration. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 250, 9–20 (1965).
Sonnenblick, E. H.: Active state in heart muscle. Its delayed onset and modification by inotropic agents. J. gen. Physiol. 50, 661–676 (1967).
Author information
Authors and Affiliations
Additional information
Supported by funds from Deutsche Forschungsgemeinschaft.
Rights and permissions
About this article
Cite this article
Reiter, M. Differences in the inotropic cardiac effects of noradrenaline and dihydro-ouabain. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 243–250 (1972). https://doi.org/10.1007/BF00500053
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00500053